Advertisements



Biotech Stock On The Radar: Is Vanda A Buy Ahead Of Its PDUFA Date?

Small-cap biopharma Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has withstood the market-wide sell-off witnessed in early August, thanks to the second-quarter report the company issued July 31. read more.....»»

Category: blogSource: benzingaAug 13th, 2019

Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma

Thinly traded micro-cap Veru Inc (NASDAQ: VERU) has added about 62% year to date — a commendable performance compared to the broader biotech sector. read more.....»»

Category: blogSource: benzingaJul 31st, 2019

Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster

The Medicines Company (NASDAQ: MDCO) stock has staged a nice recovery in the first half of 2019 after a steep 60% pullback in the second half of 2018 that dragged it to a 52-week low of $1.....»»

Category: blogSource: benzingaAug 20th, 2019

The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO

Biotech stocks came under pressure this week along with the broader market amid an earnings spate. read more.....»»

Category: blogSource: benzingaAug 11th, 2019

Ahead Of Earnings, Analysts Are Divided On Tesla

Tesla Motors Inc (NASDAQ: TSLA) is due to report its second quarter earnings July 24 after the closing bell. Though shares of the controversial automaker are down 16.5% year-to-date, the stock has rallied hard off.....»»

Category: blogSource: benzingaJul 24th, 2019

Edesa Biotech stock rockets 140% after FDA gives go-ahead to early-stage trial

Shares of Edesa Biotech Inc. shot up 140% in premarket trade after the Toronto-based company sa.....»»

Category: topSource: marketwatchJun 20th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs

For bi.....»»

Category: blogSource: benzingaJun 15th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts

Biot.....»»

Category: earningsSource: benzingaJun 8th, 2019

Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward

Shares of small-cap biotech Iovance Biotherapeutics Inc (NASDAQ: IOVA) were making a strong upward move Thursday on more than 10 times their average volume.  read more.....»»

Category: blogSource: benzingaMay 16th, 2019

Vanda Pharmaceuticals (VNDA) Q1 Earnings Top Estimates

Vanda (VNDA) delivered earnings and revenue surprises of 500.00% and -7.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks Inv.....»»

Category: dealsSource: nytMay 1st, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»

Category: blogSource: benzingaApr 27th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»

Category: earningsSource: benzingaApr 27th, 2019

Despite Recent Rally, Kinder Morgan Analyst Sees Outperformance Ahead

Kinder Morgan Inc (NYSE: KMI) reported broadly in-line results first-quarter results Wednesday. Although the oil pipeline operator's stock has appreciated 28 percent year-to-date, it will continue to attract investor attention, as.....»»

Category: earningsSource: benzingaApr 18th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts

Biotech stocks ended higher for the second straight week, with the presentations at the American Association of Cancer Research annual meeting taking the spotlight. read more.....»»

Category: blogSource: benzingaApr 7th, 2019

Is This Under-the-Radar Biotech Stock a Buy Near an All-Time High?

Repligen has grown product revenue 220% since 2014, but it trades at 70 times future earnings. What should investors make of that?.....»»

Category: topSource: foxnewsMar 25th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Biotech stocks came under pressure last week despite two FDA approvals coming through. read more.....»»

Category: blogSource: benzingaMar 23rd, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Biotech stocks came under pressure last week despite two FDA approvals coming through. The FDA approved SAGE Therapeutics Inc (NASDAQ:.....»»

Category: earningsSource: benzingaMar 23rd, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs

Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and earnings all on offer. read more.....»»

Category: blogSource: benzingaMar 10th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs

Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and&nb.....»»

Category: earningsSource: benzingaMar 10th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results an.....»»

Category: earningsSource: benzingaMar 3rd, 2019

Infosys gains 1% ahead of Q4 earnings announcement

On a year-to-date basis, the stock has rallied around 12.84%.....»»

Category: topSource: business-standardApr 13th, 2018